Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: Observations from 37,101 patients

European Heart Journal: Acute Cardiovascular Care

Volumn 3, Issue 1, 2014, Pages 37-45

  de Ferrari, Gaetano M ^a   Fox, Keith A ^b   White, Jennifer A ^c   Giugliano, Robert P ^d   Tricoci, Pierluigi ^c   Reynolds, Harmony R ^e   Hochman, Judith S ^e   Gibson, C Michael ^f   Théroux, Pierre ^g   Harrington, Robert A ^h   Van de Werf, Frans ⁱ   White, Harvey D ^j   Califf, Robert M ^c   Newby, L Kristin ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g MONTREAL HEART INSTITUTE   (Canada)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

Acute coronary syndromes; angiography; atherosclerosis; coronary disease; infarction

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRENDS;

ACUTE CORONARY SYNDROME; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84908703718     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613489315     Document Type: Article

References (26)

1. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341: 226–232.
2. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74: 531–537.
3. Bugiardini R, Manfrini O and De Ferrari GM. Unanswered questions for management of acute coronary syndrome. Risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006; 166: 1391–1395.
4. Gehrie ER, Reynolds HR, Chen AY, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: Results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009; 158: 688–694.
5. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation 2000; 102: 1101–1106.
6. Anderson JL, Adams CD, Antman EM, et al.; 2011 Writing Group Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: e426–e579.
7. De Ferrari GM, Leonardi S, Baduena L, et al. Patients with acute coronary syndrome and non-obstructive coronary disease in the real world are markedly undertreated. J Cardiovasc Med (Hagerstown) 2011; 12: 700–708.
8. Reynolds HR, Sricahi MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011; 124: 1414–1425.
9. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775–782.
10. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998; 339: 436–443.
11. PARAGON Investigators. International, randomised, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin or both in unstable angina. Circulation 1998; 97: 2386–2395.
12. Mukherjee D, Mahaffey KW, Moliterno DJ, et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). Am Heart J 2002; 144: 995–1002.
13. Ferguson JJ, Califf RM, Antman EM, et al.; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial. JAMA 2004; 292: 45–54.
14. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998; 338: 1498–1505.
15. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338: 1488–1497.
16. Giugliano RP, White JA, Bode C et al.; EARLY ACS Investigators. Early versus delayed provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009; 360: 2176–2190.
17. The Global Registry for Acute Coronary Events (GRACE). http://www.outcomes.org/grace (accessed 31 July 2012).
18. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infracting myocardium early II trial substudy. Circulation 2000; 102: 2031–2037.
19. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101: 2557–2567.
20. Eagle KA, Lim MJ, Dabbous OH et al.; GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727–2733.
21. Bairey Merz C N., Shaw LJ, Reis SE et al.; WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006; 47(3 Suppl.): S21–S29.
22. American Heart Association. Heart and Stroke 2011 Statistical Update. http://my.americanheart.org/professional/General/Heart-and-Stroke-2011-Statistical-Update_UCM_424014_Article.jsp (2011, accessed 19 December 2012).
23. Stone GW, Maehara A, Lansky AJ et al.; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226–235.
24. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009; 169: 843–850.
25. Kristensen TS, Kofoed KF, Kühl JT, et al. Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: A multidetector computed tomography study. J Am Coll Cardiol 2011; 58: 502–509.
26. Topol EJ and Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995; 92: 2333–2342.